Clinical trial · Observational
Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125
Ovarian Malignancy Incidence in Premenopausal Women Who Were at Moderate Risk for Malignancy by Risk of Malignancy Index With Low CA 125.(Retrospective Study)
NCT02247323CI-TRIAL-00049801CA125unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators are assessing the incidence of ovarian cancer in premenopausal women who were at moderate risk of malignancy with low CA125.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Risk of malignancy index | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- premenopausal women
- description
- premenopausal women with complex ovarian mass moderate for malignancy by risk of malignancy index score and low CA125.
- interventionNames
- Other: Risk of malignancy index
Primary outcomes (1)
- measure
- Incidence of ovarian malignancy
- timeFrame
- one year
- description
- Calculation of number of women who had ovarian cancer after an operation in moderate risk
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 45 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * Women with complex ovarian cyst * Abdominal pain * Menometrorrhagia Exclusion Criteria: * Significant weight loss * Cachexia * History of ovarian or other malignancy * Family history of ovarian Cancer
References
Publications (0)
Data not yet available
No reference posted for this study.